Horizon scanning: new and future therapies in the management of inflammatory bowel disease
The current mainstay treatment modalities for inflammatory bowel disease (IBD) include immunomodulators (methotrexate and thiopurines), biologics (antitumour necrosis factor alpha (TNF-α) being the most commonly used) and other monoclonal antibodies such as the anti-integrins and anti-interleukins (...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2023-10-01
|
| Series: | eGastroenterology |
| Online Access: | https://egastroenterology.bmj.com/content/1/2/e100012.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|